ARMP Armata Pharmaceuticals, Inc.
ARMP Armata Pharmaceuticals, Inc.
Healthcare · Biotechnology
Market read
POC $5.30 · VWAP $7.06 · -52.3% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
ARMP Price Structure
Loading timeframes…
Reported EPS $1.20 versus analyst consensus of $-0.44 (+368.5%).
full note →Against street estimates
How ARMP's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
Recent news
Headlines about ARMP from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 1 day ago · Oct 16
- Armata Pharmaceuticals (ARMP) Stock Price Today, News, Chart, Earnings | Coinbase
- Armata Pharmaceuticals Inc. (ARMP) Stock Price Today - WSJ
- Armata Pharmaceuticals Announces Financial Results for the Second Quarter 2026 and Provides a Corporate Update - AOL
- Press Release, dated August 12, 2026.
- Armata Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 | MarketScreener
“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.
ARMP research tape
11 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.